Okay, let's tackle this question. The patient is a 35-year-old woman with supraventricular tachycardia (SVT) and failed vagal maneuvers. The question is asking for the best therapy.

First, I need to recall the standard treatment for SVT. Vagal maneuvers like carotid sinus massage or Valsalva are first-line non-pharmacological approaches. If those don't work, the next step is usually adenosine. Adenosine works by activating A1 adenosine receptors in the AV node, which slows conduction and can terminate reentrant SVT. It's given as a rapid IV push, often with a second dose if the first doesn't work.

The other options might include other antiarrhythmics. For example, calcium channel blockers like verapamil are used in hemodynamically stable SVT but are second-line after adenosine. Beta-blockers like metoprolol can also be used. Amiodarone is more for ventricular arrhythmias, though it can be used in SVT if other options fail. Procainamide might be another option but is less commonly first-line.

So the correct answer here is adenosine. The incorrect options would be the other drugs I mentioned. Need to make sure the explanation covers why adenosine is the best choice and why the others are not first-line in this scenario.

**Core Concept**
Supraventricular tachycardia (SVT) is typically managed with adenosine as first-line pharmacologic therapy. It works by transiently blocking the AV node, interrupting reentrant circuits in SVT. Adenosine is a high-yield topic in arrhythmia management due to its rapid onset and AV node-specific action.

**Why the Correct Answer is Right**
Adenosine (6 mg rapid IV push) is the drug of choice for acute termination of SVT. It activates A1 adenosine receptors in the AV node, causing hyperpolarization and slowing conduction. Its short half-life (10 seconds) minimizes systemic effects, and it is highly effective in reentrant SVT (e.g., AV nodal reentrant tachycardia). Failure of vagal maneuvers necessitates adenosine, as it directly targets the AV node, the critical component of most SVT mechanisms.

**Why Each Wrong Option is Incorrect**
**Option A:** Verapamil (calcium channel blocker) is second-line for SVT in patients with stable hemodynamics but is contraindicated in WPW syndrome due to risk of accelerating ventricular rates.
**Option B:** Metoprolol (beta-blocker) may be used in stable SVT but is less effective than adenosine and risks unmasking underlying bradycardia.
**Option D:** Amiodarone is reserved for refractory SVT or when adenosine/verapamil are contraindicated, not as first-line therapy.

**Clinical Pearl / High-Yield Fact**
Never use calcium channel blockers or adenosine in Wolff-Parkinson-White (WPW) syndrome with SVT. Adenosine is safe in most SVT types, but in WPW, it may increase conduction via the accessory pathway—use procainamide or ibutilide instead. Remember: **"AV node

✓ Correct Answer: D. Adenosine